Table 1.
Total (n = 563) | Men (n = 456) | Women (n = 107) | p | |
---|---|---|---|---|
Age (mean ± SD), years | 64.7 ± 10.5 | 63.6 ± 10.6 | 69.5 ± 8.7 | < 0.001 |
Hospitalization days | 7 (5, 9) | 7 (5, 8) | 7 (5, 9) | 0.425 |
BMI (mean ± SD), kg/m2 | 26.03 ± 3.42 | 26.19 ± 3.42 | 25.35 ± 3.35 | 0.022 |
AC (mean ± SD), cm | 93.51 ± 9.86 | 94.3 ± 9.64 | 90.07 ± 10.11 | < 0.001 |
Smoke | 371 (65.9) | 349 (76.5) | 22 (20.6) | < 0.001 |
Drink | 113 (20.1) | 112 (24.6) | 1 (0.9) | < 0.001 |
Hypertension | 413 (73.4) | 321 (70.4) | 92 (86) | 0.001 |
Diabetes mellitus | 259 (46) | 190 (41.7) | 69 (64.5) | < 0.001 |
Hyperlipidemia | 319 (56.7) | 255 (55.9) | 64 (59.8) | 0.465 |
CAD | 344 (61.1) | 267 (58.6) | 77 (72) | 0.01 |
Previous MI | 126 (22.4) | 98 (21.5) | 28 (26.2) | 0.296 |
Heart failure | 8 (1.4) | 5 (1.1) | 3 (2.8) | 0.179 |
Chronic kidney disease | 34 (6) | 26 (5.7) | 8 (7.5) | 0.488 |
Peripheral vascular disease | 42 (7.5) | 32 (7) | 10 (9.3) | 0.409 |
Stroke | 121 (21.5) | 92 (20.2) | 29 (27.1) | 0.116 |
History of PCI | 176 (31.3) | 141 (30.9) | 35 (32.7) | 0.719 |
History of CABG | 23 (4.1) | 21 (4.6) | 2 (1.9) | 0.198 |
CHOL(mmol/L) | 4.02 ± 106 | 3.96 ± 1.04 | 4.32 ± 1.11 | 0.002 |
LDL-C(mmol/L) | 2.28 ± 0.75 | 2.24 ± 0.73 | 2.42 ± 0.79 | 0.028 |
eGFR(ml/min) | 83.4 ± 22.11 | 84.68 ± 21.56 | 77.95 ± 23.67 | 0.005 |
NT-proBNPmax (pg/ml) | 370 (106.5, 1337.5) | 328 (94.53, 1196.75) | 582 (135.5, 2152.5) | 0.044 |
Values are n (%), mean ± SD, or median with interquartile range
AC abdominal circumference, CAD coronary artery disease, PCI percutaneous coronary intervention, CABG coronary artery bypass graft, CHOL cholesterol, LDL-c low-density lipoprotein cholesterol, NT-proBNP N-terminal pro-brain natriuretic peptide, eGFR estimated glomerular filtration rate